Utility of endogenous 4β-hydroxycholesterol as a biomarker to assess cytochrome P 450 3A (CYP3A) activity: not quite ready for prime time

Eur J Clin Pharmacol. 2022 Nov;78(11):1863-1864. doi: 10.1007/s00228-022-03386-z. Epub 2022 Sep 13.
No abstract available

Keywords: 4β-hydroxycholesterol; Biomarker; CYP3A4.

Publication types

  • Review

MeSH terms

  • Biomarkers
  • Cytochrome P-450 CYP3A*
  • Humans
  • Hydroxycholesterols*

Substances

  • Biomarkers
  • Hydroxycholesterols
  • cholest-5-ene-3,4-diol
  • Cytochrome P-450 CYP3A